• A friendly and supportive community, register today. Our forums use a separate account system.

Australia Bioxyne exceeds revenue guidance with German deal set to ‘underpin growth into FY26’

revenue-growth-300x162.png


Alternative medicine manufacturer Bioxyne generated unaudited revenue of A$29.3 million in FY25, exceeding guidance by $1.3m. […]

The post Bioxyne exceeds revenue guidance with German deal set to ‘underpin growth into FY26’ appeared first on Cannabiz.

Continue reading...
 
Click to expand...

  Similar Discussions (Automatically Generated)

Cannabiz
  • Article Article
Australia Bioxyne upgrades FY25 revenue forecast to $28m
Replies
0
Views
65
Cannabiz
Cannabiz
Cannabiz
  • Article Article
Australia Bioxyne stays on course to hit A$25m revenue guidance despite Q3 fall
Replies
0
Views
90
Cannabiz
Cannabiz
Cannabiz
  • Article Article
Australia Pastilles drive Bioxyne to first half profit after revenue climbs 171%
Replies
1
Views
192
BudGuy
BudGuy
Cannabiz
  • Article Article
Australia Bioxyne inks $7m deal with NectarTek Australia
Replies
0
Views
120
Cannabiz
Cannabiz
Cannabiz
  • Article Article
Australia Bioxyne upgrades revenue forecast on back of record Q2
Replies
0
Views
136
Cannabiz
Cannabiz
Back
Top